Tyrosine and aurora kinase inhibitors diminish transport function of multidrug resistance-associated protein (MRP) 4 and breast cancer resistance protein (BCRP). ADMET and DMPK, [S. l.], v. 4, n. 4, p. 302–313, 2016. DOI: 10.5599/admet.4.4.322. Disponível em: https://pub.iapchem.org/ojs/index.php/admet/article/view/322. Acesso em: 17 nov. 2025.